packageCobimetinib

cobimetinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Cobimetinib is a MEK inhibitor anticancer drug used to treat melanoma, including metastatic melanoma. It is authorised in the European Union for melanoma and is also under investigation for other uses.

Summary written by glm-5.3-flash from Wikidata Q15708292 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:cobimetinib
ATC codes:L01EE02, L01XE38
DrugBank:DB05239
PubChem CID:16222096
ChEBI:90851
Wikidata:Q15708292
formula:C21H21F3IN3O2
molar mass:531.312 g/mol (PubChem CID 16222096)
logP:3.9 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown